{"url_path":"/sec/cldi/8-k/2026-07-16/item-1-01","section_key":"item-1-01","section_title":"Item 1.01 Entry into a Material Definitive Agreement.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-07-16","source_url":"https://www.sec.gov/Archives/edgar/data/1855485/0001493152-26-033594-index.html","accession_number":"0001493152-26-033594","cik":"0001855485","ticker":"CLDI","issuer_name":"Calidi Biotherapeutics, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1855485/0001493152-26-033594-index.html","primary_entity_key":"0001855485","primary_entity_name":"Calidi Biotherapeutics, Inc."},"word_count":347,"has_tables":true,"body_markdown":"**Item\n1.01. Entry into a Material Definitive Agreement.**\n\n** **\n\nOn\nJuly 10, 2026, Calidi Biotherapeutics, Inc. (the “**Company**”) entered into a lease agreement (the “**New Lease**”)\nwith BP3-SD4 5580 Morehouse Drive LLC, a Delaware limited liability company (the “**New Landlord**”), pursuant to which\nthe Company will lease approximately 9,038 rentable square feet of office and laboratory space located in Suite 120 at 5580 Morehouse\nDrive, San Diego, California 92121 (the “**New Premises**”). The New Landlord is an affiliate of 4475 Executive Drive\nLLC, the landlord under the Company’s existing lease described in Item 1.02 below.\n\n \n\nThe\nCompany estimates it will save approximately $1.1 million per year in rent and facility-related expenses by terminating the existing\nlease and entering into the New Lease. \n\n \n\nThe\nNew Lease has an initial term of 44 months, scheduled to commence on October 1, 2026 and expire on May 31, 2030, subject to the terms\nof the New Lease and the tenant work letter attached thereto. The Company has one option to extend the term of the New Lease for an additional\nthree years at the then-prevailing fair market rental rate, subject to the conditions set forth in the New Lease, including that the\nCompany has not previously been in default under the New Lease and occupies at least 50% of the New Premises at the time of exercise.\n\n \n\nWithin\n10 calendar days following execution of the New Lease, the Company is required to deliver an irrevocable letter of credit in the amount\nof $113,574.78. The letter of credit must generally remain in effect until at least 120 days following the expiration of the New Lease\nand may be drawn by the New Landlord following certain customary events specified in the New Lease. The New Lease contains customary\nevents of default and remedies.\n\n \n\nThe\nforegoing description of the New Lease does not purport to be complete and is qualified in its entirety by reference to the full text\nof the New Lease, a copy of which is filed as Exhibit 10.1 to this Current Report on Form 8-K and is incorporated herein by reference."}